APA (7th ed.) Citation

K, H., S, S., W, W., M, K., L, H., KW, K., . . . DR, W. (2026). Oral Nutritional Supplements and Body Composition Outcomes Among GLP-1 Receptor Agonist Users: Real-World Evidence. Diabetes, metabolic syndrome and obesity : targets and therapy, 19, 574765. https://doi.org/10.2147/DMSO.S574765

Chicago Style (17th ed.) Citation

K, Hong, Sulo S, Wang W, Kim M, Hong L, Kerr KW, Fan L, and Williams DR. "Oral Nutritional Supplements and Body Composition Outcomes Among GLP-1 Receptor Agonist Users: Real-World Evidence." Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy 19 (2026): 574765. https://doi.org/10.2147/DMSO.S574765.

MLA (9th ed.) Citation

K, Hong, et al. "Oral Nutritional Supplements and Body Composition Outcomes Among GLP-1 Receptor Agonist Users: Real-World Evidence." Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy, vol. 19, 2026, p. 574765, https://doi.org/10.2147/DMSO.S574765.